These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 780372)

  • 21. Comparison of serotype, biotype and bacteriocin type with rDNA RFLP patterns for the type identification of Serratia marcescens.
    Alonso R; Aucken HM; Perez-Diaz JC; Cookson BD; Baquero F; Pitt TL
    Epidemiol Infect; 1993 Aug; 111(1):99-107. PubMed ID: 8102336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compatible results obtained from biotyping and serotyping in Serratia marcescens.
    Grimont PA; Grimont F; Le Minor S; Davis B; Pigache F
    J Clin Microbiol; 1979 Oct; 10(4):425-32. PubMed ID: 393712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two nosocomial outbreaks of sepsis caused by Serratia marcescens, which occurred in July 1999 and January 2002--Tokyo].
    Endoh M; Okuno R; Mukaigawa J; Shimojima Y; Murata I; Morozumi S; Sekine H; Marumo K
    Kansenshogaku Zasshi; 2004 Apr; 78(4):295-304. PubMed ID: 15176233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
    Marumo K; Nakamura Y; Sakurai C
    Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [O-serotypes, biotypes and antimicrobial susceptibilities of Serratia marcescens isolates from clinical specimens: 4th report].
    Marumo K; Nakamura Y; Fukuda S
    Rinsho Byori; 1995 Nov; 43(11):1140-6. PubMed ID: 8551678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative biotyping, bacteriocin typing, and serogrouping (O-antigens) of Serratia liquefaciens.
    Traub WH
    Zentralbl Bakteriol; 1991 Jun; 275(2):200-10. PubMed ID: 1718303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Numerical analysis of SDS-PAGE protein patterns of Serratia marcescens: a comparison with other typing methods.
    Holmes B; Costas M; Sloss LL
    Epidemiol Infect; 1990 Aug; 105(1):107-17. PubMed ID: 2200696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of RAPD-PCR as a typing method for Serratia marcescens.
    Hejazi A; Keane CT; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):913-9. PubMed ID: 9368531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of three nosocomial outbreaks of Serratia marcescens in an intensive care unit in Sfax-Tunisia].
    Ktari S; Mahjoubi F; Mnif B; Kallel H; Bouaziz M; Hammami A
    Tunis Med; 2010 Jul; 88(7):501-6. PubMed ID: 20582888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Serratia marcescens populations of nosocomial origin by RAPD-PCR.
    Enciso-Moreno JA; Pernas-Buitrón N; Ortiz-Herrera M; Coria-Jiménez R
    Arch Med Res; 2004; 35(1):12-7. PubMed ID: 15036794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [O-serotypes, biotypes, and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens: 3rd report].
    Marumo K; Nagaki T; Nakamura Y
    Rinsho Byori; 1992 Dec; 40(12):1312-8. PubMed ID: 1307637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An examination of the clonal variants of Serratia marcescens that infect the eye during contact lens wear.
    Hume EB; Willcox MD; Sweeney DF; Holden BA
    J Med Microbiol; 1996 Aug; 45(2):127-32. PubMed ID: 8683548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotyping of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C; Cruz-Camarillo R
    Rev Latinoam Microbiol; 1992; 34(4):253-8. PubMed ID: 1345114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved O-serotyping method for Serratia marcescens.
    Gaston MA; Pitt TL
    J Clin Microbiol; 1989 Dec; 27(12):2702-5. PubMed ID: 2480362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of pyrolysis mass spectrometry to investigate nosocomial outbreaks caused by Serratia marcescens.
    Nagy E; Koczián Z; Prágai Z; Sisson PR; Freeman R
    Acta Microbiol Immunol Hung; 2000; 47(4):433-43. PubMed ID: 11056763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotyping of Serratia marcescens: simplified tube O-agglutination test and comparison with other serological procedures.
    Traub WH; Fukushima PI
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):474-93. PubMed ID: 396741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of strains of Serratia marcescens isolated from neonates with strains isolated from sporadic and epidemic infections in adults.
    Gaston MA; Hoffman PN; Pitt TL
    J Hosp Infect; 1986 Jul; 8(1):86-95. PubMed ID: 2875106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.